Intraobserver and Interobserver Reproducibility on Hip Clinical Assessment

October 24, 2017 updated by: Marco Aurélio Vaz, PhD, Federal University of Rio Grande do Sul
The functional assessment of the hip joint is complex and challenging. Reproducible measures are necessary to identify changes in the structures and functionality of the hip joint over time and to evaluate the outcomes of treatments. A systematic evaluation process is critical to evidence-based practice. However, there are few studies investigating the reproducibility of these measures such as muscle strength, range of motion (ROM) and hip functionality in healthy subjects.

Study Overview

Status

Completed

Conditions

Detailed Description

Twenty subjects were randomized in two different days: (1) First evaluation of muscle strength, range of motion and single-leg squat performed by the evaluator 1; (2) Repeat the first evaluation with 3 different evaluators

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rio Grande do Sul
      • Porto Alegre, Rio Grande do Sul, Brazil, 90690-200
        • Exercise Research Laboratory, School of Physical Education, Federal University of Rio Grande do Sul

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Male healthy subjects

Description

Inclusion Criteria:

  • No complaints of pain or knowledge of hip pathology
  • Subjects willing to enroll

Exclusion Criteria:

  • Subjects reporting that they can not perform the tests due to pain
  • With previous surgery of the hip or pelvis;
  • Diabetes Mellitus;
  • Neuromuscular or neurological diseases;
  • Cardiovascular diseases that prevent the realization of maximum voluntary effort;
  • Subjects presenting positive hip clinical tests

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Other

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hip muscle strength
Time Frame: Day 1 (evaluator 1) and after 4 days of rest repeat measures on day 2 with 3 different evaluators
Measured with isometric hand hel dynamometry
Day 1 (evaluator 1) and after 4 days of rest repeat measures on day 2 with 3 different evaluators

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hip range of motion
Time Frame: Day 1 (evaluator 1) and after 4 days of rest repeat measures on day 2 with 3 different evaluators
Measured with goniometer
Day 1 (evaluator 1) and after 4 days of rest repeat measures on day 2 with 3 different evaluators

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Single-leg squat
Time Frame: Day 1 (evaluator 1) and after 4 days of rest repeat measures on day 2 with 3 different evaluators
Hip adduction angle
Day 1 (evaluator 1) and after 4 days of rest repeat measures on day 2 with 3 different evaluators

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 13, 2017

Primary Completion (Actual)

May 19, 2017

Study Completion (Actual)

August 31, 2017

Study Registration Dates

First Submitted

March 9, 2017

First Submitted That Met QC Criteria

March 9, 2017

First Posted (Actual)

March 15, 2017

Study Record Updates

Last Update Posted (Actual)

October 26, 2017

Last Update Submitted That Met QC Criteria

October 24, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • UFRGS 1.822.689

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Joint

3
Subscribe